Concepedia

Fukang Yang

FY

Statistics

Publications

14

Citations

475

H-Index

13

Active since

1996

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Wisconsin–Milwaukee

Fukang Yang is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1996–2025

14

Publications

14

Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir

Makonen Belema, Van N. Nguyen, Carol Bachand et al. · Journal of Medicinal Chemistry · 2014 · 87 citations · Full text

, , +17

Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes

J. Romine, Denis R. St. Laurent, John E. Leet et al. · ACS Medicinal Chemistry Letters · 2011 · 86 citations

, , +17

HCV NS5A Replication Complex Inhibitors. Part 4.1 Optimization for Genotype 1a Replicon Inhibitory Activity

Denis R. St. Laurent, Michael H. Serrano‐Wu, Makonen Belema et al. · Journal of Medicinal Chemistry · 2013 · 35 citations

, , +15

The synthesis of S-(+)-2,2-dimethylcyclopropane carboxylic acid: a precursor for cilastatin

Qingwei Wang, Fukang Yang, Hong Du et al. · Tetrahedron Asymmetry · 1998 · 34 citations

, , +6

Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents

Yong‐Jin Wu, Jason Guernon, Fukang Yang et al. · ACS Medicinal Chemistry Letters · 2016 · 31 citations · Full text

, , +13

1–5 of 14